GordonMD Global Investments

Funding rounds backed by GordonMD Global Investments.

Export CSV
Funding disclosed in full
$57.7M
Median round
$28.9M
Rounds in calculation
2
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Cyllene Therapeutics

Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases

€33MSeries CBiotechFrance
5 participantsBpifrance InvestissementGordonMD Global InvestmentsLamond VenturesMerck Ventures B.V.T. Andera Partners SAS
Rapalogix Health

Develops prescription therapeutics and skincare products for cellular longevity and skin health

$20MSeries ABiotechUnited States
2 participantsGordonMD Global InvestmentsWoodline Partners